Figure 5.
Effect of a Janus kinase inhibitor on mumps virus infectivity. Selected tumor cells lines were treated with Ruxolitinib, a Janus kinase inhibitor, at the indicated doses. After 48 hours the treated and controlled cells were infected with rMuV-UC-GFP mumps virus (multiplicity of infection (MOI,. 10). Fluorescent images were taken 5 days postinfection. GFP, green fluorescent protein.